Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1
Abstract Background Pulmonary hypertension (PH) is a devastating disease characterized by vasoconstriction and vascular remodeling, leading to right ventricular failure and death. PH is a common complication of chronic obstructive pulmonary disease (COPD). Accumulating evidence demonstrate that micr...
Main Authors: | Zhao Yang, Ping Li, Qun Yuan, Xi Wang, Hong-Hong Ma, Bing Zhuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-023-02387-5 |
Similar Items
-
MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway
by: Chenli Chang, et al.
Published: (2024-02-01) -
Antiproliferative effect of selexipag active metabolite MRE‐269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension
by: Kazuya Kuramoto, et al.
Published: (2023-04-01) -
Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis
by: Xinghua Xiao, et al.
Published: (2022-08-01) -
Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
by: Elizabeth Córdoba-Lanús, et al.
Published: (2023-08-01) -
Knockdown of circ_0006872 alleviates CSE-induced human bronchial epithelial cells injury in chronic obstructive pulmonary disease
by: Jieqiong Wang, et al.
Published: (2023-02-01)